Drug interactions between Allergy Pain Relief and Suphedrine PE Sinus & Allergy
| Results for the following 2 drugs: |
|---|
| Allergy Pain Relief (acetaminophen/chlorpheniramine/phenylephrine) |
| Suphedrine PE Sinus & Allergy (chlorpheniramine/phenylephrine) |
Interactions between your drugs
Allergy Pain Relief
A total of 966 drugs (5656 brand and generic names) are known to interact with Allergy Pain Relief.
- Allergy Pain Relief is in the drug class upper respiratory combinations.
- Allergy Pain Relief is used to treat the following conditions:
Suphedrine PE Sinus & Allergy
A total of 893 drugs (5152 brand and generic names) are known to interact with Suphedrine PE Sinus & Allergy.
- Suphedrine PE Sinus & Allergy is a member of the drug class upper respiratory combinations.
- Suphedrine PE Sinus & Allergy is used to treat the following conditions:
Drug and food interactions
chlorpheniramine food
Applies to: Allergy Pain Relief (acetaminophen / chlorpheniramine / phenylephrine), Suphedrine PE Sinus & Allergy (chlorpheniramine / phenylephrine)
Alcohol can increase the nervous system side effects of chlorpheniramine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with chlorpheniramine. Do not use more than the recommended dose of chlorpheniramine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Antihistamines
Therapeutic duplication
The recommended maximum number of medicines in the 'antihistamines' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'antihistamines' category:
- chlorpheniramine (active ingredient in Allergy Pain Relief (acetaminophen/chlorpheniramine/phenylephrine))
- chlorpheniramine (active ingredient in Suphedrine PE Sinus & Allergy (chlorpheniramine/phenylephrine))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Decongestants
Therapeutic duplication
The recommended maximum number of medicines in the 'decongestants' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'decongestants' category:
- phenylephrine (active ingredient in Allergy Pain Relief (acetaminophen/chlorpheniramine/phenylephrine))
- phenylephrine (active ingredient in Suphedrine PE Sinus & Allergy (chlorpheniramine/phenylephrine))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Sympathomimetic amines
Therapeutic duplication
The recommended maximum number of medicines in the 'sympathomimetic amines' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'sympathomimetic amines' category:
- phenylephrine (active ingredient in Allergy Pain Relief (acetaminophen/chlorpheniramine/phenylephrine))
- phenylephrine (active ingredient in Suphedrine PE Sinus & Allergy (chlorpheniramine/phenylephrine))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Sympathomimetics
Therapeutic duplication
The recommended maximum number of medicines in the 'sympathomimetics' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'sympathomimetics' category:
- phenylephrine (active ingredient in Allergy Pain Relief (acetaminophen/chlorpheniramine/phenylephrine))
- phenylephrine (active ingredient in Suphedrine PE Sinus & Allergy (chlorpheniramine/phenylephrine))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
